Recombinant Rat CLIC1 Protein, His (Fc)-Avi-tagged

• Cat.No.: CLIC1-1106R
• Product Overview: Recombinant Rat CLIC1 with His (Fc)-Avi tag was expressed and purified

Specification

• Source: HEK293
• Species: Rat
• Tag: His&Fc&Avi
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
• Purity: ≥85% by SDS-PAGE
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
• Storage: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Clic1 chloride intracellular channel 1 [ Rattus norvegicus ]
• Official Symbol: CLIC1
• Gene ID: 406864
• mRNA Refseq: NM_001002807.2
• Protein Refseq: NP_001002807.1
• UniProt ID: Q6MG61

Reviews

12/12/2022

With the manufacturer's outstanding technical support, you can be assured that any challenges you encounter will be efficiently addressed.

07/26/2020

Its superior quality, combined with the manufacturer's exceptional technical support, provides researchers with the confidence they need to conduct successful experiments and obtain meaningful results.

11/04/2018

Researchers who have utilized the CLIC1 protein laud its reliability and effectiveness in their studies.

Q&As

How does CLIC1 protein contribute to cancer progression?

CLIC1 protein promotes cancer cell proliferation, migration, and invasion, making it a potential target for cancer therapy.

Are there any clinical trials targeting CLIC1 protein in cancer therapy?

Several clinical trials are investigating the efficacy of CLIC1 protein-targeted therapies in various types of cancer, including breast, lung, and colorectal cancer.

How does CLIC1 protein contribute to cardiovascular disorders?

CLIC1 protein has been linked to cardiac hypertrophy, fibrosis, and arrhythmias, suggesting its involvement in the pathogenesis of cardiovascular diseases.

Can CLIC1 protein be used as a therapeutic target in neurodegenerative diseases?

Yes, targeting CLIC1 protein has shown promise in preclinical studies as a potential therapeutic approach for neurodegenerative diseases.

How is CLIC1 protein involved in neurodegenerative diseases?

CLIC1 protein has been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where it may play a role in neuronal dysfunction and neuroinflammation.